Concepedia
Publication | Open Access
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
326
Citations
24
References
2020
Year
ClinicalTrials.gov Identifier: NCT02919683.
Page 1